FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas
Clinical trial NCT03042780 · TERMINATED
Trial details
- NCT number
- NCT03042780
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2018-01-03
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.